Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)

Not Applicable

Completed

Conditions: Mild Cognitive Impairment
Dementia

Interventions: Behavioral: Resources and Activities for Life Long Independence (RALLI)
Behavioral: Social Walking program (SW)

First Posted Date: 2007-03-12

Last Posted Date: 2012-10-19

Lead Sponsor: University of Washington

Target Recruit Count: 181

Registration Number: NCT00446394

Locations: 🇺🇸
Northwest Research Group on Aging, Department of Psychosocial and Community Health, University of Washington School of Nursing, Seattle, Washington, United States

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Phase 2

Completed

Conditions: Kidney Failure, Chronic
Diabetic Nephropathies
Glomerulonephritis, IGA
Hypertension, Renal

First Posted Date: 2007-03-12

Last Posted Date: 2010-04-15

Lead Sponsor: University of Washington

Target Recruit Count: 45

Registration Number: NCT00446459

Locations: 🇺🇸
Universtiy of Washington Medical Center, Seattle, Washington, United States

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Phase 2

Completed

Conditions: Kidney Failure, Chronic
Diabetic Nephropathies
Glomerulonephritis, IGA
Hypertension, Renal

First Posted Date: 2007-03-12

Last Posted Date: 2010-04-06

Lead Sponsor: University of Washington

Target Recruit Count: 14

Registration Number: NCT00446251

SPHERE Hypertension Baseline Data Study

Completed

Conditions: Hypertension

First Posted Date: 2007-03-07

Last Posted Date: 2008-02-15

Lead Sponsor: University of Washington

Target Recruit Count: 470

Registration Number: NCT00444496

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Computer Assisted Rx Education for HIV-Positives: CARE+

Not Applicable

Completed

Conditions: HIV Infections
Acquired Immunodeficiency Syndrome

Interventions: Behavioral: CARE+

First Posted Date: 2007-03-06

Last Posted Date: 2008-01-29

Lead Sponsor: University of Washington

Target Recruit Count: 240

Registration Number: NCT00443378

Locations: 🇺🇸
Lifelong AIDS Alliance, Seattle, Washington, United States
🇺🇸
Madison Clinic, Harborview Medical Center, Seattle, Washington, United States

Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity

Phase 2

Conditions: Contraception

Interventions: Drug: Ortho-Cyclen (R)
Drug: Ortho Evra (R)
Drug: extended use of Ortho Evra (R)

First Posted Date: 2007-02-26

Last Posted Date: 2011-02-14

Lead Sponsor: University of Washington

Target Recruit Count: 36

Registration Number: NCT00439972

Locations: 🇺🇸
University of Washington, Northwest Lipid Research Clinic, Seattle, Washington, United States

SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

Phase 2

Completed

Conditions: Mild Cognitive Impairment
Alzheimer's Disease

Interventions: Drug: Placebo
Drug: Regular Insulin

First Posted Date: 2007-02-22

Last Posted Date: 2012-09-14

Lead Sponsor: University of Washington

Target Recruit Count: 173

Registration Number: NCT00438568

Locations: 🇺🇸
Veterans Administration Puget Sound Health Care System, Seattle, Washington, United States

Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer

Phase 1

Completed

Conditions: Stage III Ovarian Epithelial Cancer
Stage IV Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IV Ovarian Epithelial Cancer
Stage IV Ovarian Germ Cell Tumor
HER2-positive Breast Cancer
Stage IIIC Breast Cancer
Stage III Ovarian Germ Cell Tumor

Interventions: Biological: pNGVL3-hICD vaccine
Biological: sargramostim
Other: flow cytometry
Other: immunologic technique
Other: immunoenzyme technique
Genetic: protein expression analysis
Procedure: biopsy

First Posted Date: 2007-02-19

Last Posted Date: 2025-04-06

Lead Sponsor: University of Washington

Target Recruit Count: 66

Registration Number: NCT00436254

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Effect of Diesel Exhaust Particulate Exposures on Endothelial Function in Humans

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: N-acetylcysteine, ascorbate
Drug: Placebo

First Posted Date: 2007-02-12

Last Posted Date: 2013-01-16

Lead Sponsor: University of Washington

Target Recruit Count: 24

Registration Number: NCT00434005

Locations: 🇺🇸
Northlake Laboratory, Seattle, Washington, United States

Does Block Play Improve Language Acquisition: A Randomized Trial

Not Applicable

Completed

Conditions: Healthy

First Posted Date: 2007-01-30

Last Posted Date: 2008-09-29

Lead Sponsor: University of Washington

Target Recruit Count: 200

Registration Number: NCT00428376

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy